Dyne Therapeutics (DYN) Prepaid Assets (2019 - 2026)
Dyne Therapeutics (DYN) posted quarterly Prepaid Assets of $39.4 million for Q2 2026, up 181.03% year-over-year from $14.0 million in Q2 2025, and down 19.35% quarter-over-quarter from $48.9 million in Q1 2026.
Dyne Therapeutics (DYN) Prepaid Assets (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has reported Prepaid Assets for 8 consecutive years, with $39.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Prepaid Assets rose 181.03% year-over-year to $39.4 million; the TTM figure through Jun 2026 stood at $39.4 million (up 181.03% YoY), while the FY2025 annual figure was $16.0 million, down 5.8% from the prior year.
- Prepaid Assets fell to $39.4 million in Q2 2026 per DYN's latest filing, from $48.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $48.9 million in Q1 2026 and bottomed at $5.4 million in Q2 2023.
- Historically, Prepaid Assets has averaged $16.8 million across 5 years, with a median of $13.1 million in 2024.
- On a YoY basis, Prepaid Assets climbed as much as 434.77% in 2022 and fell as far as 76.29% in 2022.
- Dyne Therapeutics' Prepaid Assets stood at $9.6 million in 2022, then plunged by 34.51% to $6.3 million in 2023, then surged by 171.09% to $17.0 million in 2024, then slipped by 5.8% to $16.0 million in 2025, then jumped by 145.95% to $39.4 million in 2026.
- Business Quant data shows DYN's Prepaid Assets at $39.4 million in Q2 2026, $48.9 million in Q1 2026, and $16.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Dyne Therapeutics | 4.26 Bn | 4.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.41 Mn |
| Mar 31, 2026 | 48.87 Mn |
| Dec 31, 2025 | 16.03 Mn |
| Sep 30, 2025 | 14.38 Mn |
| Jun 30, 2025 | 14.03 Mn |
| Mar 31, 2025 | 12.01 Mn |
| Dec 31, 2024 | 17.01 Mn |
| Sep 30, 2024 | 12.72 Mn |
| Jun 30, 2024 | 13.48 Mn |
| Mar 31, 2024 | 34.59 Mn |
| Dec 31, 2023 | 6.28 Mn |
| Sep 30, 2023 | 10.39 Mn |
| Jun 30, 2023 | 5.44 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 9.58 Mn |
| Sep 30, 2022 | 10.09 Mn |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 21.30 Mn |
| Dec 31, 2021 | 5.82 Mn |
| Sep 30, 2021 | 17.13 Mn |